May 26, 2015 Cerenis Therapeutics featured prominently at the INTERNATIONAL SYMPOSIUM ON ATHEROSCLEROSIS (IAS)
May 26, 2015 Onxeo Announces Final Data from Completed Phase II Trial of Validive® for the Prevention of Severe Oral Mucositis in Head and Neck Cancer Patients
May 15, 2015 Statement by the Board of Directors of Aerocrine in relation to Circassia’s public cash offer
May 15, 2015 Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
May 14, 2015 Cortendo and Antisense Therapeutics Announce Licensing Agreement for ATL1103 for Acromegaly
May 12, 2015 Frost & Sullivan Acclaims BONESUPPORT’s Growth Potential Bolstered by its Unique Platform Technology, CERAMENT™